# Trinidad and Tobago Chemicals Export Opportunities (HS 28-38) ![Yugalinks](https://www.yugalinks.com/trade/yugalinks-logo-v3-dark-mode.webp) > Yugalinks sector export playbook Explore Trinidad and Tobago HS 28-38 chemicals export opportunities, product portfolio, buyer markets, growth signals, and diversification opportunities. ## Overview - Exporter: Trinidad and Tobago (TTO) - Sector: Chemicals - HS chapters: HS 28-38 - Latest trade year: 2024 - Sector exports: $781.8K - Products: 26 - Buyer markets: 21 - Average CAGR: -4.8% - Global sector size: $460.3B ## Product portfolio | Product | Global size | Your exports | Opportunity | CAGR | Markets | Share | | --- | ---: | ---: | ---: | ---: | ---: | ---: | | HS 300490 - Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $255.0B | $114.5K | $91.3B | -1.0% | 15 | +0.0% | | HS 300215 - Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale | $71.9B | $1.7 | $27.4B | -36.6% | 2 | +0.0% | | HS 300220 - Vaccines: for human medicine | $18.2B | $2.1K | $15.6B | -4.1% | 2 | +0.0% | | HS 382499 - Chemical products, mixtures and preparations: n.e.c. heading 3824 | $22.7B | $81.3K | $15.1B | +12.5% | 10 | +0.0% | | HS 330210 - Odoriferous substances and mixtures: of a kind used in the food or drink industries | $9.6B | $403.0K | $12.1B | +6.0% | 5 | +0.0% | | HS 382200 - Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | $16.8B | $8.7K | $6.8B | +1.1% | 6 | +0.0% | | HS 330499 - Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | $12.2B | $39.0K | $5.3B | +1.2% | 5 | +0.0% | | HS 300439 - Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | $12.1B | $8.8K | $5.2B | +6.2% | 2 | +0.0% | | HS 300212 - Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions | $8.5B | $0.4 | $4.3B | -98.4% | 1 | +0.0% | | HS 330300 - Perfumes and toilet waters | $5.1B | $34.4 | $2.7B | -22.5% | 1 | +0.0% | | HS 340220 - Washing and cleaning preparations: surface-active, whether or not containing soap (excluding those of heading no. 3401), put up for retail sale | $2.3B | $15.5K | $2.1B | +13.4% | 2 | +0.0% | | HS 300420 - Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | $3.8B | $195.3 | $2.0B | -1.9% | 1 | +0.0% | | HS 281820 - Aluminium oxide: other than artificial corundum | $2.2B | $0.0 | $1.8B | -91.4% | 1 | +0.0% | | HS 300290 - Toxins, cultures of micro-organisms (excluding yeasts) and similar products | $3.2B | $61.9 | $1.6B | -11.5% | 2 | +0.0% | | HS 300670 - Pharmaceutical goods: Gel preparations designed to be used in human or veterinary medicine as a lubricant for parts of the body for surgical operations or physical examinations or as a coupling agent between the body and medical instruments | $1.2B | $50.1 | $1.4B | +11.6% | 1 | +0.0% | | HS 284410 - Uranium: natural uranium and its compounds, alloys, dispersions (including cermets), ceramic products and mixtures containing natural uranium or natural uranium compounds | $1.6B | $15.7 | $1.4B | -10.8% | 1 | +0.0% | | HS 290110 - Acyclic hydrocarbons: saturated | $916.4M | $3.8 | $1.3B | -61.6% | 1 | +0.0% | | HS 300390 - Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | $1.8B | $4.4 | $1.2B | -1.4% | 1 | +0.0% | | HS 330290 - Odoriferous substances and mixtures: used as raw materials in industries other than the food or drink industries | $1.3B | $236.1 | $803.3M | -11.0% | 1 | +0.0% | | HS 310210 - Fertilizers, mineral or chemical: nitrogenous, urea, whether or not in aqueous solution | $2.3B | $72.4K | $746.8M | -26.8% | 1 | +0.0% | | HS 280920 - Phosphoric acid and polyphosphoric acids | $2.0B | $44.2 | $744.2M | -25.5% | 1 | +0.0% | | HS 290511 - Alcohols: saturated monohydric, methanol (methyl alcohol) | $787.3M | $762.3 | $694.7M | -55.8% | 1 | +0.0% | | HS 284440 - Radioactive elements, isotopes, compounds, n.e.c. in heading no. 2844 alloys, dispersions (including cermets), ceramic products and mixtures containing these elements, isotopes or compounds: radioactive residues | $927.2M | $17.1K | $685.1M | +4.9% | 1 | +0.0% | | HS 381800 - Chemical elements: doped for use in electronics, in the form of discs, wafers or similar forms: chemical compounds doped for use in electronics | $1.5B | $566.4 | $645.9M | -19.6% | 1 | +0.0% | | HS 340600 - Candles, tapers and the like | $1.0B | $173.3 | $640.9M | -18.1% | 1 | +0.0% | | HS 300660 - Pharmaceutical goods: chemical contraceptive preparations based on hormones or spermicides | $1.2B | $17.2K | $604.6M | +15.8% | 1 | +0.0% | ## Best markets - USA, Puerto Rico and US Virgin Islands (USA): $87.5B calculated opportunity across 20 products. - Switzerland, Liechtenstein (CHE): $27.7B calculated opportunity across 1 products. - Belgium (BEL): $15.0B calculated opportunity across 2 products. - Canada (CAN): $12.3B calculated opportunity across 8 products. - Germany (DEU): $10.1B calculated opportunity across 5 products. - United Kingdom (GBR): $8.0B calculated opportunity across 4 products. - Netherlands (NLD): $7.9B calculated opportunity across 4 products. - Mexico (MEX): $6.9B calculated opportunity across 3 products. - France (FRA): $6.5B calculated opportunity across 5 products. - Italy (ITA): $4.9B calculated opportunity across 1 products. - Ireland (IRL): $3.8B calculated opportunity across 2 products. - China (CHN): $3.8B calculated opportunity across 1 products. ## Growth stars - HS 300660: +15.8% average CAGR, $604.6M calculated opportunity. - HS 340220: +13.4% average CAGR, $2.1B calculated opportunity. - HS 382499: +12.5% average CAGR, $15.1B calculated opportunity. - HS 300670: +11.6% average CAGR, $1.4B calculated opportunity. - HS 300439: +6.2% average CAGR, $5.2B calculated opportunity. - HS 330210: +6.0% average CAGR, $12.1B calculated opportunity. - HS 284440: +4.9% average CAGR, $685.1M calculated opportunity. - HS 330499: +1.2% average CAGR, $5.3B calculated opportunity. - HS 382200: +1.1% average CAGR, $6.8B calculated opportunity. - HS 300490: -1.0% average CAGR, $91.3B calculated opportunity. ## Diversification opportunities - HS 300490: 15 buyer markets, $91.3B calculated opportunity. - HS 382499: 10 buyer markets, $15.1B calculated opportunity. - HS 382200: 6 buyer markets, $6.8B calculated opportunity. - HS 330210: 5 buyer markets, $12.1B calculated opportunity. - HS 330499: 5 buyer markets, $5.3B calculated opportunity. - HS 300215: 2 buyer markets, $27.4B calculated opportunity. - HS 300220: 2 buyer markets, $15.6B calculated opportunity. - HS 300439: 2 buyer markets, $5.2B calculated opportunity. - HS 340220: 2 buyer markets, $2.1B calculated opportunity. - HS 300290: 2 buyer markets, $1.6B calculated opportunity. ## Method Reported trade observations and calculated indicators are shown separately. Validate buyers, standards, logistics, pricing, and competition before acting. [Read the Yugalinks methodology](https://www.yugalinks.com/methodology). ## Data sources - Primary trade series: OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). [OECD Data Explorer](https://data-explorer.oecd.org/) - [OECD Terms & Conditions](https://www.oecd.org/termsandconditions/) - CEPII BACI bilateral trade flows (202601): [dataset page](https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37) - [BACI documentation](https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html) - [Etalab 2.0 Open Licence](https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf) This page presents derived Yugalinks views of reported observations and calculated indicators.